drugset / Trial / NCT02968160
A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Randomized, open-label, 2 groups, parallel design.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-02
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |